CareDx

CareDx, Inc. is a precision medicine company dedicated to improving the lives of transplant patients and their caregivers through innovative healthcare solutions. The company specializes in genomics-based diagnostics, offering a range of products including AlloSure Kidney, a non-invasive test that measures donor-derived cell-free DNA in kidney transplant patients, and AlloMap Heart, a gene expression profiling test for heart transplant recipients. CareDx also provides additional solutions such as Olerup SSP and TruSight HLA for human leukocyte antigen typing, AlloSeq cfDNA for post-transplant monitoring, and various software solutions for transplant administration. These products support the entire transplant journey, from initial donor-recipient matching to ongoing patient care and monitoring. CareDx markets its services directly to healthcare providers and through third-party distributors, and it has established partnerships for the development of advanced diagnostic technologies. The company, originally named XDx, Inc., was founded in 1998 and is headquartered in South San Francisco, California.